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Previous studies have established that gene transfer into myocardial cells in vivo is detectable after direct injection of plasmid DNA. Recently, adenovirus vectors have been shown to provide an efficient method for gene transfer into a wide range of tissues. Therefore, this study sought to assess the efficiency and stability of adenovirus-mediated gene transfer into myocardium and to compare this method with that using plasmid-based gene transfer techniques. Adult rats underwent myocardial injection via a subdiaphragmatic approach. Gene transfer efficiency was compared using direct injection of an adenovirus vector encoding for the marker gene f-galactosidase (/-gal), a control adenovirus vector encoding for the cystic fibrosis transmembrane conductance regulator gene, a plasmid encoding for /-gal, or a control plasmid. Hearts infected with an adenovirus vector containing the P-gal gene showed significantly increased (3-gal enzymatic activity compared with hearts injected with ,B-gal plasmid. Histological examination revealed that cardiac myocytes were the target of adenovirus-mediated gene transfer. A time course of gene expression showed that /-gal enzymatic activity peaked during the first week following injection. Adenovirus vectors provide an efficient but transient method for in vivo gene expression in myocardium. (Circ Res. 1993 ;73:1202-1207.)
KEY WORDS * gene therapy * adenovirus P revious studies have demonstrated the feasibility of in vivo gene transfer into myocardial cells by direct injection of plasmid DNA.1-6 Although these studies of gene transfer using naked DNA have been encouraging, estimates of the number of myocytes that can be transfected in vivo have been as low as 60 to 100 cells per injection.3 This low efficiency might hinder efforts to study the effects of expression of transfected genes in myocytes. In addition, such a low efficiency might not be expected to achieve a clinical effect.
Recently, adenovirus vectors have been shown to be efficient in transferring exogenous genes into a wide variety of cell types in vivo.7-18 Adenovirus vectors have several advantages over other gene transfer methods. These include the possibility of generating viral stocks in excess of 1 x 1011 plaque-forming units (pfu)/mL, the ability to accept heterologous genes up to 7.5 kb in length, and, of particular importance in myocardial gene transfer, the capacity to infect both replicating and nonreplicating cells.11~19 The potential for efficient myocardial gene transfer using adenovirus vectors has been suggested by a previous report of myocardial gene expression following intravenous injection of recombinant virus in newborn mice. 10 The present report studies the potential utility of adenovirus-mediated myocardial gene transfer by direct injection and demonstrates that such methods are sig-nificantly more efficient than direct injection of plasmid DNA.
Materials and Methods

Adenovirus and Plasmid Vectors
The replication-deficient recombinant adenovirus (Ad.RSV,3gal) has been previously described.'0,13
Briefly, the recombinant virus encodes for the histochemical marker gene ,3-galactosidase (,3-gal). The ,B-gal gene has been modified by the addition of sequences encoding for a nuclear translocation signal and is placed under the control of the Rous sarcoma virus (RSV) long terminal repeat. Expression of the 13-gal gene product results in a nuclear-dominant blue staining pattern when cells are exposed to the chromogen 5 -bromo-4 -chloro-3 -indoyl-13-D-galactopyranoside (X-gal). A similar adenovirus containing the cystic fibrosis transmembrane conductance regulator cDNA (AdCFTR),1" whose recombinant gene product does not react with the X-gal chromogen, was used as a viral control. Viral stocks of 1 x 1010 to 5 x 1010 pfu/mL were prepared by passaging recombinant adenovirus in 293 cells. 8"11,20 Two plasmid vectors were used. The first was the eukaryotic expression plasmid pRSVflgal, which contains 13-gal driven by the RSV promoter.' The second plasmid, pCMV-neo, encodes for neomycin resistance, a gene product that does not react with the X-gal chromogen.
Animals
A total of 50 adult Sprague-Dawley rats weighing 375 to 425 g were studied under protocols approved by the . Animals were maintained on a normal diet. All procedures were performed under general anesthesia and using sterile technique. Rats were anesthetized using ketamine (15 mg/100 g) and xylazine (1.5 mg/100 g IM) and given supplemental ketamine/xylazine intraperitoneally as necessary. On completion of each procedure, the animals were allowed to recover with free access to food and water. Two animals died immediately after the procedure because of pneumothorax and were excluded from further analysis.
Myocardial Injections In Vivo
After initiation of general anesthesia, a midline, longitudinal, subxiphoid incision was made, and the peritoneal cavity was entered. The abdominal contents were pushed inferiorly, and the heart was visualized through the diaphragm. A 100 4L solution of medium M199 (Biofluids, Rockville, Md) containing either 5 x 108 pfu adenovirus (approximately 25 jig viral DNA) or 200 ,ug plasmid DNA was injected directly into the myocardium through the diaphragm using a 25-gauge needle. Injections were made into the posterolateral portion of the heart to attempt consistent needle placement into the cardiac apex. The abdominal contents were then restored to their normal anatomic position, and the incision was closed in two layers using interrupted 4-0 Vicryl suture.
Evaluation of Gene Transfer
For histological evaluations, animals were killed 3 days (n=9), 2 weeks (n=3), or 1 month (n=3) after injection. The abdomen was entered, and the heart was perfused with 200 mL normal saline in a retrograde manner using an 18-gauge catheter inserted into the abdominal aorta. The heart was then excised and dissected free of aorta and surrounding tissues. Hearts were then fixed in a solution containing 2% formaldehyde and 0.2% glutaraldehyde in phosphate-buffered saline (PBS) at pH 7.4 and cut into sections approximately 2 mm thick. The sections from the entire heart were then washed three times in PBS and placed in X-gal solution containing 5 mmol/L K4Fe(CN)6, 5 mmol/L K3Fe(CN)6, 1 mmol/L MgCl2, and 1 mg/mL X-gal in PBS for 2 hours. Samples were subsequently processed for gross and microscopic histological analysis.
For assessment of ,3-gal enzymatic activity, 33 animals were injected with Ad.RSVf3gal, pRSV,Bgal, AdCFTR, or pCMV-neo. They were then killed at the indicated time after injection by overdosing with 100 mg IP pentobarbital. After retrograde perfusion with normal saline, hearts were immersed in 2 mL ice-cold PBS containing the protease inhibitors phenylmethanesulfonyl fluoride (1 U/mL) and aprotinin (0.2 U/mL). The myocardium was then cut into small pieces (<1 mm) and homogenized for 30 seconds in a Beckmann polytron. Homogenates were then stored at -80°C before further processing or directly lysed by 5 cycles of freeze-thawing. Cell lysates were then centrifuged at 14 00g for 5 minutes at 4°C, and the supernatant was transferred to a new tube. Enzymatic activity was measured in a reaction volume of 300 ,uL consisting of 30 ,uL cell lysate, 3 ,uL buffer A (0.1 mol/L MgCl2 and 4.5 mol/L f,-mercaptoethanol), 66 ,L of a 4 j,g/mL solution of o-nitroprenol-,8-D-galactoside, and 201 ,tL of 0.1 mol/L sodium phosphate buffer, pH 7.5. After 30 minutes at 37°C, the reaction was stopped by adding 500 ,uL of 1 mol/L Na2CO3. The optical density of each sample was then read at 420 nm to determine activity as previously described. 13 Activity was normalized for protein concentration, which was determined by using a modified Lowry assay (Pierce, Rockford, Ill). Comparisons between two or more groups were performed using the ANOVA test statistic with a value of P<.05 considered significant.
Results
Improved 13-Gal Expression in Heart Muscle
Gene transfer was initially assessed 3 days after injection by histological staining with X-gal. As seen in Fig 1A, after injection of a plasmid encoding P-gal, a small region of myocardium was stained after exposure to X-gal. This level of gene transfer is consistent with what has been previously reported.1 In contrast, direct injection of the adenovirus vector Ad.RSV,Bgal led to a marked increase in gene transfer. As seen in Fig  1B, a transmural region of myocardium, presumably corresponding to the needle tract, stained positive with X-gal. Hearts injected with a control adenovirus (AdCFTR) showed no evidence of 13-gal gene transfer ( Fig 1C) . Histological examination of Ad.RSV,Bgalinjected hearts (Fig 1D) demonstrated that the target is the cardiac myocyte. The 13-gal staining was confined to the nucleus, consistent with the nuclear localization signal included in the adenoviral construct. As seen in Fig 1D, there is also a considerable inflammatory response, predominantly composed of mononuclear cells, in the injected area. Histological examination of hearts injected with AdCFTR showed no evidence of 13-gal expression, but a similar inflammatory response was noted ( Fig 1E) .
To quantify gene transfer efficiency, injected hearts were assessed for p-gal enzymatic activity. Since injections were not performed under direct visualization, a lysate from the entire heart rather than a specific region was used. As seen in Fig 1F, when (3-gal enzymatic activity was assessed 3 days after injection, hearts injected with Ad.RSV,Bgal showed measurable levels of 13-gal activity. This was significantly higher (P<.01 by ANOVA) than that seen in the three other groups that were injected with control plasmid DNA, a control adenovirus, or a plasmid encoding 13-gal. Since the level of gene transfer with a 13-gal plasmid is confined to low levels in a small histological area ( Fig   1A) , it is perhaps not surprising that 13-gal enzymatic activity could not be detected in a lysate prepared from the entire myocardium.
To assess the persistence of gene expression, hearts were assessed for 13-gal enzymatic activity at 1, 3, 7, 14, and 21 days after injection. As seen in Fig 2A, t9 point was possibly related to technical aspects of myocardial injection in the absence of direct visualization. However, a large variation was also seen in measurements of myocardial luciferase activity after plasmidmediated gene transfer under direct visualization.5.21 Statistical analysis demonstrated that enzymatic activity in hearts at 1 and 3 days after injection was significantly greater than that of uninjected hearts (P<.02 after 1 day, P<.01 after 3 days). To obtain a visual assessment of the persistence of gene expression, hearts were harvested 10 to 15 days after injection and stained with X-gal. These hearts showed decreased f3-gal staining (Fig 2B) when compared with hearts harvested 3 days after injection ( Fig  IB) . However, hearts harvested 30 or more days after injection failed to show any enzymatic or histological evidence of fl-gal gene expression ( Fig 2C) . 
Discussion
The use of gene therapy for the treatment of myocardial diseases requires an efficient gene transfer vector and a practical delivery system. Previous reports have suggested that direct injection of plasmid DNA led to detectable gene transfer into both skeletal and cardiac muscle.1-6 Although this provided a practical delivery system, the reported efficiencies appeared to be too low to confer either a therapeutic benefit or to allow easy assessment of the biologic effects of heterologous gene expression. The present study demonstrates that direct injection of replicationdeficient recombinant adenovirus provides a simple, transient, and significantly improved method of myocardial gene transfer.
Previously, both subdiaphragmatic and thoracic approaches have been used to inject plasmid DNA into -( 0 CL c2 CD X., the myocardium.l-6 Although the thoracic approach allows direct visualization of the heart, it is complicated by the need for intubation with ventilation and a higher mortality rate in our hands. Therefore, we chose to use a subdiaphragmatic approach similar to that previously used.3 With this approach, the heart is easily visualized through the diaphragm, and direct injection of the apex can be approximated through posterolateral needle placement. An additional advantage is that the entire procedure can be performed in under 10 minutes and with minimal mortality (less than 5% in our study).
We were unable to detect significantly increased ,3-gal enzymatic activity 1 week after injection (Fig 2A) , although by histological staining (X-gal) myocytes still remained positive for several weeks (Fig 2B) . This indicates that enzymatic activity measured in the lysate obtained from the total heart is a relatively insensitive assay for gene transfer. The insensitivity of the assay presumably also explains why, although visually detectable, we were unable to detect an increase in ,3-gal enzymatic activity in hearts injected with the pRSV,3gal plasmid compared with control hearts. Previous reports have not quantified ,-gal gene transfer by enzymatic activity but have instead used more sensitive reporter genes. 3, 5 It is unclear why p-gal gene expression persists for only days to weeks after injection. A previous report suggested that gene expression in newborn mice persisted for up to 12 months after adenoviral infection.10 However, several reports using plasmid-mediated gene transfer into cardiac myocytes35,6 as well as adenovirusmediated gene transfer into endothelial cells in vivol8 have shown a transient time course of gene expression similar to ours. Since adenovirus is not thought to integrate into the genome of the host cell,19 it is possible that the viral genome could be lost after cell division. However, such an explanation seems unlikely to play a role in the nondividing cardiac myocytes. Other explanations for the transient nature of expression include the possibility that the viral genome persists but becomes inactivated or, alternatively, that the infected cells express some virally encoded or induced antigens that lead to an immunologic selection against the infected cells. Since the adenoviral constructs used in this study lack the El region of the virus, which is required for expression of early adenovirus genes and for viral replication, it is thought that no viral gene products are made after infection.
Although we noted an acute inflammatory response in our hearts injected with adenovirus ( Fig 1C) , we and others'21 have seen a similar inflammatory response after injection of plasmid DNA. This suggests that the observed inflammatory response may be more related to the injury produced by direct injection than to the stimulation of an immunologic response to viral gene products.
Although adenovirus-mediated myocardial gene transfer is considerably more efficient than direct injection of plasmid DNA, the transient nature of gene product expression means that its therapeutic utility will be limited. It is possible, however, that future studies will identify the factors that account for the transient nature of gene expression using adenovirus vectors, information that might eventually lead to interventions that will extend expression of gene products. Alternatively, the development of other viral vectors such as adeno-associated virus, which differs from adenovirus in that it more often integrates into the genome of the host cell, may provide for longer term expression. 22 On the other hand, recent studies suggest that short intracoronary infusions of fibroblast growth factor given over a period of only 7 days may accelerate angiogenesis in vivo, an effect that persists long after administration of growth factor is discontinued (E. Unger, personal communication). This suggests that recombinant adenovirus, engineered to encode for angiogenic factors, may provide enough of a stimulus to initiate collateral development even if it is only expressed transiently. In addition, the ability of adenovirus vectors to efficiently transduce a transmural region of myocardium allows for the potential in vivo assessment of candidate genes whose products may have physiological or regulatory effects or may influence infarct size, arrhythmogenicity, or systolic/diastolic function. Thus, adenovirus-mediated gene transfer may serve as a therapeutic modality in specific situations and as a useful research tool in furthering our understanding of myocyte function and control.
